Evidence map›Paper›PMID 39746990›Full record

ArticleNature communications2025

FYN regulates aqueous humor outflow and IOP through the phosphorylation of VE-CADHERIN.

Krishnakumar Kizhatil, Graham M Clark, Daniel K Sunderland, Aakriti Bhandari, Logan J Horbal, Revathi Balasubramanian, Simon W M John

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Chromatin accessibility regulates age-dependent nuclear mechanotransduction.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Krishnakumar KizhatilDepartment of Ophthalmology and Visual Sciences, The Ohio State Medical Center, Columbus, Ohio, 43210, USA. Krishnakumar.Kizhatil@osumc.edu.ORCID 0000-0003-3755-6101
Graham M ClarkThe Jackson Laboratory, Bar Harbor, Maine, 04609, USA.
Daniel K SunderlandThe Jackson Laboratory, Bar Harbor, Maine, 04609, USA.
Aakriti BhandariThe Jackson Laboratory, Bar Harbor, Maine, 04609, USA.
Logan J HorbalThe Jackson Laboratory, Bar Harbor, Maine, 04609, USA.
Revathi BalasubramanianDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA.
Simon W M JohnDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY, USA. sj2967@cumc.columbia.edu.ORCID 0000-0002-4319-0356

Funding

Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Cell Death Pathways in Glaucomatous NeurodegenerationR01EY018606 · NEI · UNIVERSITY OF ROCHESTER · PI JOHN, SIMON W, LIBBY, RICHARD T · 2008 to 2023
$5.8M
The Ohio State University Vision Sciences Research Core Program (OSU-VSRCP)P30EY032857 · NEI · OHIO STATE UNIVERSITY · PI Sayoko E Moroi · 2022 to 2026
$3.6M
Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk?R01EY032062 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JOHN, SIMON W, KIZHATIL, KRISHNAKUMAR · 2021 to 2025
$3.5M
Models, mechanisms and treatment of LMX1B-induced glaucomaR01EY032507 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JOHN, SIMON W · 2021 to 2024
$2.3M
Determining How Lymphatic Molecules Control Conventional OutflowR01EY028175 · NEI · JACKSON LABORATORY · PI KIZHATIL, KRISHNAKUMAR · 2017 to 2021
$2.3M
BrightFocus Foundation (BrightFocus) BFOCUS CG2020004BrightFocus Foundation (BrightFocus) CG2020004NEI NIH HHS P30 EY019007NEI NIH HHS P30 EY032857NEI NIH HHS R01 EY018606NEI NIH HHS R01 EY028175NEI NIH HHS R01 EY032062NEI NIH HHS R01 EY032507Research to Prevent Blindness (RPB) UnrestrictedU.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) R01EY018606U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) R01EY028175U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) R01EY032062U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) R01EY032507
6 · The paper itself

Abstract

Schlemm's canal endothelial cells (SECs) serve as the final barrier to aqueous humor (AQH) drainage from the eye. SECs adjust permeability to AQH outflow to modulate intraocular pressure (IOP). The broad identification of IOP-related genes implicates SECs in glaucoma. However, the molecular mechanisms by which SECs sense and respond to pressure changes to regulate fluid permeability and IOP remain largely undefined. We hypothesize that mechano-responsive phosphorylation of the cell adhesion molecule VE-CADHERIN (CDH5) in SECs, by FYN and possibly other SRC family kinases, regulates adherens junction (AJ) permeability to AQH in response to IOP. On experimentally raising IOP in mouse eyes, AJ permeability, CDH5 phosphorylation, and FYN activation at the AJ all increase. FYN null mutant mice display disrupted IOP regulation and reduced AQH outflow. These findings demonstrate an important role of mechanotransducive signaling within SECs in maintaining IOP homeostasis and implicate FYN as a potential target for developing IOP-lowering treatments.

Indexed as

Antigens, CDAqueous HumorCadherinsIntraocular PressureMice, KnockoutProto-Oncogene Proteins c-fynAdherens JunctionsAnimalsCadherin 5Endothelial CellsHumansMaleMiceMice, Inbred C57BLPhosphorylationAntigens, CDCadherin 5CadherinsFyn protein, mouseProto-Oncogene Proteins c-fyn

Identifiers

PMID39746990
PMCPMC11696269

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.